BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2410397)

  • 1. Biological activity of cadeguomycin. Inhibition of tumor growth and metastasis, immunostimulation, and potentiation of 1-beta-D-arabinofuranosylcytosine.
    Yuan BD; Wu RT; Sato I; Okabe T; Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1985 May; 38(5):642-8. PubMed ID: 2410397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
    Suzuki H; Kim SH; Tanara M; Okazaki K; Okabe T; Wu RT; Tanaka N
    Cancer Res; 1987 Feb; 47(3):713-7. PubMed ID: 3467840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and metastasis in association with modification of immune response by novel organic germanium compounds.
    Sato I; Yuan BD; Nishimura T; Tanaka N
    J Biol Response Mod; 1985 Apr; 4(2):159-68. PubMed ID: 3998767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities of IC201 ((3S,8E)-1,3-dihydroxy-8-decen-5-one), a low molecular weight immunomodulator produced by Streptomyces.
    Mizutani S; Odai H; Masuda T; Iijima M; Osono M; Hamada M; Naganawa H; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1989 Jun; 42(6):952-9. PubMed ID: 2786863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of pyrimidine nucleoside uptake into K562 and YAC-1 cells by cadeguomycin.
    Wu RT; Okabe T; Kim SH; Suzuki H; Tanaka N
    J Antibiot (Tokyo); 1985 Nov; 38(11):1588-95. PubMed ID: 2416726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5'-nucleotidase inhibitors on mouse immune system and experimental murine tumors.
    Uchino K; Ogawara H; Akiyama T; Watanabe S; Fukuchi A
    J Antibiot (Tokyo); 1986 May; 39(5):682-7. PubMed ID: 2426233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of cadeguomycin analogs.
    Kim SH; Okazaki K; Okabe T; Nishimura T; Kondo T; Tanaka N; Suzuki H
    J Antibiot (Tokyo); 1991 Jun; 44(6):659-64. PubMed ID: 2071491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on antineoplastic activity of naphthomycin, a naphthalenic ansamycin, and its mode of action.
    Okabe T; Yuan BD; Isono F; Sato I; Fukazawa H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1985 Feb; 38(2):230-5. PubMed ID: 3997667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A.
    Ishizuka M; Takeuchi T; Masuda T; Fukasawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Mar; 34(3):331-40. PubMed ID: 6456249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadeguomycin, a noval nucleoside analog antibiotic. I. The producing organism, production and isolation of cadeguomycin.
    Tanaka N; Wu RT; Okabe T; Yamashita H; Shimazu A; Nishimura T
    J Antibiot (Tokyo); 1982 Mar; 35(3):272-8. PubMed ID: 7076575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 10-hydroxy-2-decenoic acid on phagocytosis and cytokines production of peritoneal macrophages in vitro.
    Wang GY; Lin ZB
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):180-2. PubMed ID: 10072977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulation-mediated antitumor activity by preconditioning with rice-shochu distillation residue against implanted tumor in mice.
    Seki T; Morimura S; Ohba H; Tang Y; Shigematsu T; Maeda H; Kida K
    Nutr Cancer; 2008; 60(6):776-83. PubMed ID: 19005977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of an antibiotic identical with or closely related to xanthomycin A.
    Nishimura T; Kitajima J; Omura S; Tanaka N
    J Antibiot (Tokyo); 1981 Jul; 34(7):856-61. PubMed ID: 7287588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of blastolysin on the ultrastructure and phagocytic activity of peritoneal macrophages].
    Zhukov VG; Teleshov VA; Gukasian IA; Ogarkov VI
    Arkh Patol; 1985; 47(8):39-45. PubMed ID: 4074147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
    Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
    Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cadeguomycin on cytotoxicity of cytosine arabinoside and other pyrimidine nucleoside analogs; a comparative study.
    Kim SH; Okabe T; Tanaka N; Suzuki H
    J Antibiot (Tokyo); 1987 Dec; 40(12):1776-7. PubMed ID: 3429344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.